Coagulation studies are NOT required before performance of the procedure
Incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)
No data supports cutoff values beyond which<unk>  should be avoided/prophylactically transfused
Routine use of FFP and platelets is not recommended
Procedure is contraindicated if the patient is actively bleeding or in DIC
Incidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)
Paracentesis
Theraputic peritoneal lavage
Thoracentesis
Hemodialysis/Hemoperfusion
Multidose activated charcoal
Transjugular intrahepatic portosystemic shunt
Activated charcoal
Plasmapheresis